Waleed H Hassanein sold $8.0M of TMDX
President & CEO at TransMedics Group, Inc.. 68,444 shares at an average of $116.68, traded May 1, 2024, filed May 3, 2024.
Score components
- +25RoleCEO
- +25Trade size$8.0M at market
- +20Share of holdings soldSold 53% of holdings
- +15Cluster7 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +6.6%, 3m +17.3%, 6m -35.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-052964, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 1, 2024 | MOption exercise Common Stock10b5-1 | +56,000 | $13.28 | $744k | 130,087 | May 3, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock10b5-1 | -2,685 | $105.56 | $283k | 127,402 | May 3, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock10b5-1 | -91 | $106.51 | $9,692 | 127,311 | May 3, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock10b5-1 | -424 | $107.57 | $46k | 126,887 | May 3, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock10b5-1 | -6,800 | $110.00 | $748k | 120,087 | May 3, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock10b5-1 | -23,500 | $114.17 | $2.7M | 96,587 | May 3, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock10b5-1 | -22,500 | $120.25 | $2.7M | 74,087 | May 3, 2024 |
| May 2, 2024 | SOpen-market sale Common Stock10b5-1 | -6,140 | $120.64 | $741k | 67,947 | May 3, 2024 |
| May 2, 2024 | SOpen-market sale Common Stock10b5-1 | -6,222 | $122.16 | $760k | 61,725 | May 3, 2024 |
| May 2, 2024 | SOpen-market sale Common Stock10b5-1 | -82 | $122.67 | $10k | 61,643 | May 3, 2024 |
| May 1, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -56,000 | $0.00 | $0 | 178,000 | May 3, 2024 |
Related signals
Other insiders at TransMedics Group, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | TMDXbuy TransMedics Group, Inc. | David Weill director | $109k 1,336 shares | +9% | |
| 31Weak | TMDXsell TransMedics Group, Inc. | Thomas James Gunderson director | $722k 9,624 shares | -37% | |
| 52Moderate | TransMedics Group, Inc. | Stephanie Lovell director | $178k 1,193 shares | -29% | |
| 38Weak | TransMedics Group, Inc. | David Weill director | $524k 3,571 shares | -23% | |
| 46Moderate | TransMedics Group, Inc. | Nicholas Corcoran See remarks | $413k 2,966 shares | -9% | |
| 67Notable | TransMedics Group, Inc. | Gerardo Hernandez Chief Financial Officer | $1.1M 7,611 shares | -51% | |
| 40Moderate | TransMedics Group, Inc. | Anil P. Ranganath See remarks | $120k 864 shares | -6% | |
| 48Moderate | TransMedics Group, Inc. | Gerardo Hernandez Chief Financial Officer | $128k 920 shares | -6% | |
| 46Moderate | TransMedics Group, Inc. | David Weill director | $693k 5,000 shares | -29% | |
| 37Weak | TransMedics Group, Inc. | Anil P. Ranganath See remarks | $436k 3,000 shares | -18% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.